Rapid Medical, a company focused on the development of neurovascular interventional devices, announced recently that the first patient has been treated with its CE marked TIGERTRIEVER revascularization device. The TIGERTRIEVER uses Rapid Medical’s unique and proprietary technology enabling the first fully-visible, controllable stentriever that can be adjusted by the physician to perfectly fit the dimensions of blocked blood vessels that cause acute ischemic stroke.
The TIGERTRIEVER makes use of Rapid Medical’s proprietary technology platform based on more than 7 years of experience in controllable and visible advanced braided stent design to accomplish both excellent continuous adjustability and high radial force.
Rapid Medical plans to launch the TIGERTRIEVER in Europe during Q2 2016.
Rapid Medical
www.rapid-medical.com